Pfizer and BioNTech will run three simultaneous trials in adults 18 to 55 to determine if an omicron-specific vaccine is more effective than current shots LM OTERO/AP
Karen Weintraub USA TODAY Vaccine makers Pfizer and BioNTech announced plans early Tuesday to test an omicron-specific COVID-19 vaccine in people. The companies will run…
